Protalix BioTherapeutics Statistics
Total Valuation
PLX has a market cap or net worth of $121.40 million. The enterprise value is $94.15 million.
Important Dates
The next confirmed earnings date is Thursday, August 14, 2025, before market open.
| Earnings Date | Aug 14, 2025 |
| Ex-Dividend Date | n/a |
Share Statistics
PLX has 79.61 million shares outstanding. The number of shares has decreased by -5.05% in one year.
| Current Share Class | 79.61M |
| Shares Outstanding | 79.61M |
| Shares Change (YoY) | -5.05% |
| Shares Change (QoQ) | -26.56% |
| Owned by Insiders (%) | 10.62% |
| Owned by Institutions (%) | 17.13% |
| Float | 60.63M |
Valuation Ratios
The trailing PE ratio is 19.76 and the forward PE ratio is 4.94.
| PE Ratio | 19.76 |
| Forward PE | 4.94 |
| PS Ratio | 1.98 |
| Forward PS | 3.86 |
| PB Ratio | 2.78 |
| P/TBV Ratio | 2.45 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Financial Ratio HistoryEnterprise Valuation
| EV / Earnings | 15.00 |
| EV / Sales | 1.52 |
| EV / EBITDA | 9.81 |
| EV / EBIT | 11.44 |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 2.72, with a Debt / Equity ratio of 0.11.
| Current Ratio | 2.72 |
| Quick Ratio | 1.78 |
| Debt / Equity | 0.11 |
| Debt / EBITDA | 0.47 |
| Debt / FCF | n/a |
| Interest Coverage | 8.82 |
Financial Efficiency
Return on equity (ROE) is 15.99% and return on invested capital (ROIC) is 9.35%.
| Return on Equity (ROE) | 15.99% |
| Return on Assets (ROA) | 6.05% |
| Return on Invested Capital (ROIC) | 9.35% |
| Return on Capital Employed (ROCE) | 15.12% |
| Revenue Per Employee | $290,836 |
| Profits Per Employee | $29,460 |
| Employee Count | 213 |
| Asset Turnover | 0.73 |
| Inventory Turnover | 1.26 |
Taxes
In the past 12 months, PLX has paid $1.81 million in taxes.
| Income Tax | 1.81M |
| Effective Tax Rate | 22.42% |
Stock Price Statistics
The stock price has increased by +47.13% in the last 52 weeks. The beta is -0.22, so PLX's price volatility has been lower than the market average.
| Beta (5Y) | -0.22 |
| 52-Week Price Change | +47.13% |
| 50-Day Moving Average | 1.50 |
| 200-Day Moving Average | 1.95 |
| Relative Strength Index (RSI) | 50.28 |
| Average Volume (20 Days) | 522,797 |
Short Selling Information
| Short Interest | n/a |
| Short Previous Month | n/a |
| Short % of Shares Out | n/a |
| Short % of Float | n/a |
| Short Ratio (days to cover) | n/a |
Income Statement
In the last 12 months, PLX had revenue of $61.95 million and earned $6.28 million in profits. Earnings per share was $0.08.
| Revenue | 61.95M |
| Gross Profit | 35.64M |
| Operating Income | 8.23M |
| Pretax Income | 6.77M |
| Net Income | 6.28M |
| EBITDA | 9.60M |
| EBIT | 8.23M |
| Earnings Per Share (EPS) | $0.08 |
Full Income StatementBalance Sheet
The company has $33.40 million in cash and $5.35 million in debt, giving a net cash position of $28.05 million or $0.35 per share.
| Cash & Cash Equivalents | 33.40M |
| Total Debt | 5.35M |
| Net Cash | 28.05M |
| Net Cash Per Share | $0.35 |
| Equity (Book Value) | 49.90M |
| Book Value Per Share | 0.63 |
| Working Capital | 41.39M |
Full Balance SheetCash Flow
In the last 12 months, operating cash flow was -$2.20 million and capital expenditures -$1.25 million, giving a free cash flow of -$1.56 million.
| Operating Cash Flow | -2.20M |
| Capital Expenditures | -1.25M |
| Free Cash Flow | -1.56M |
| FCF Per Share | -$0.02 |
Full Cash Flow StatementMargins
Gross margin is 57.53%, with operating and profit margins of 13.28% and 10.13%.
| Gross Margin | 57.53% |
| Operating Margin | 13.28% |
| Pretax Margin | 13.06% |
| Profit Margin | 10.13% |
| EBITDA Margin | 15.49% |
| EBIT Margin | 13.28% |
| FCF Margin | n/a |
Dividends & Yields
PLX does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | 5.05% |
| Shareholder Yield | 5.05% |
| Earnings Yield | 5.14% |
| FCF Yield | -1.28% |
Analyst Forecast
The average price target for PLX is $15.00, which is 883.61% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $15.00 |
| Price Target Difference | 883.61% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 1 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Stock ForecastsFair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | |
| Graham Upside | |
Stock Splits
The last stock split was on December 20, 2019. It was a reverse split with a ratio of 1:10.
| Last Split Date | Dec 20, 2019 |
| Split Type | Reverse |
| Split Ratio | 1:10 |
Scores
| Altman Z-Score | n/a |
| Piotroski F-Score | 3 |
